Autolus Therapeutics (AUTL) Asset Utilization Ratio (2020 - 2025)
Autolus Therapeutics posted quarterly Asset Utilization Ratio of 0.12 for Q4 2025, up 857.98% year-on-year from 0.01 in Q4 2024, and up 63.0% on a QoQ basis from 0.07 in Q3 2025.
Autolus Therapeutics (AUTL) has 6 years of Asset Utilization Ratio data on file, last reported at 0.12 in Q4 2025.
- For the quarter ending Q4 2025, Asset Utilization Ratio rose 857.98% year-over-year to 0.12; the trailing twelve-month figure through Dec 2025 stood at 0.12 (up 857.98% YoY), and the FY2025 full-year result was 0.11, up 528.9% from the prior year.
- Asset Utilization Ratio for Q4 2025 stood at 0.12, up from 0.07 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.12 in Q4 2025 and bottomed at 0.0 in Q3 2022.
- The 5-year median for Asset Utilization Ratio is 0.01 (2021), against an average of 0.02.
- The widest annual swing landed in 2022, when Asset Utilization Ratio slumped 145.97%; it then surged 887.06% in 2023.
- A 5-year view of Asset Utilization Ratio shows it stood at 0.0 in 2021, then plunged by 81.22% to 0.0 in 2022, then soared by 887.06% to 0.0 in 2023, then soared by 189.51% to 0.01 in 2024, then surged by 857.98% to 0.12 in 2025.
- The last three Asset Utilization Ratio figures came in at 0.12 (Q4 2025), 0.07 (Q3 2025), and 0.04 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 0.60 |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 0.47 |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 0.37 |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 0.29 |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 0.85 |
| 10 | Autolus Therapeutics | - | - | -1.04 Mn | 0.12 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.12 |
| Sep 30, 2025 | 0.07 |
| Jun 30, 2025 | 0.04 |
| Mar 31, 2025 | 0.01 |
| Dec 31, 2024 | 0.01 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | 0.01 |
| Mar 31, 2024 | 0.02 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.01 |
| Jun 30, 2021 | 0.01 |
| Mar 31, 2021 | 0.00 |
| Dec 31, 2020 | 0.00 |
| Sep 30, 2020 | 0.00 |